Navamedic expands cooperation with Pohl-Boskamp
Oslo, 3 March 2016 - Navamedic ASA (OSE: NAVA) the Norwegian medtech and pharmaceutical marketing- and distribution company today announced an expanded cooperation agreement with German pharmaceutical manufacturer, Pohl-Boskamp, for distribution of Nitrolingual® Pumpspray in the Nordic markets. Nitrolingual® Pumpspray is an oral spray of nitroglycerine used for relief or prevention of sudden attacks of chest pain associated with angina pectoris caused by heart disease. Annual sales of Nitrolingual® in the Nordic markets are expected to be around NOK 8 million. "Our cooperation with